BACKGROUND. Eleven nineteen lysine-rich leukemia (ELL) plays an important role in tumorigenesis and animal development. HIF-1 is a transcriptional factor that functions as a master regulator of O-2 homeostasis. Our previous studies showed that a binding partner of ELL, U19/Eaf2, can modulate HIF-1 alpha activity and hypoxia response, suggesting that ELL may also influence HIF-1 alpha pathway and hypoxia response. METHODS. Co-localization and co-immunoprecipitation were performed to test the interaction between ELL and HIF-1 alpha. PC3 cells with stable ELL knockdown and PC3 cells with stable ELL overexpression, along with their controls, were established using lentiviral expression system. Western blot and real-time PCR were performed to te...
Hypoxia-inducible factor (HIF)-1 alpha accumulation promotes hematopoietic stem cells' quiescence an...
The eleven-nineteen lysine-rich leukemia (ELL) gene undergoes translocation and fuses in-frame to th...
Oncogenesis is governed by genetic and epigenetic events that co-opt to malignant progression. The r...
ELL (eleven-nineteen lysine-rich leukemia protein) was first identified as a translocation partner o...
Background: U19/EAF2 is a potential tumor suppressor exhibiting frequent down-regulation and allelic...
Previous studies revealed that the potential tumor suppressor EAF2 binds to and stabilizes pVHL, sug...
Primary effusion lymphoma (PEL) is an aggressive B-cell lymphoma with poor prognosis caused by Kapos...
Matching oxygen consumption and supply represents a fundamental challenge to multicellular organisms...
AbstractChronic lymphocytic leukemia (CLL), the most common adult leukemia in the Western world, is ...
Overcoming resistance to chemotherapy is the main therapeutic challenge in the treatment of acute ly...
The mechanisms by which AML1/ETO (A/E) fusion protein induces leukemogenesis in acute myeloid leukem...
The objective of this study was to determine the effect of hypoxic conditions on the expression of H...
The mechanisms by which AML1/ETO (A/E) fusion protein induces leukemogenesis in acute myeloid leukem...
Rampant activity of the hypoxia-inducible factor (HIF)-1 in cancer is frequently associated with the...
Upon exposing mammalian tissues to hypoxia, expression of a number of physiologically important gene...
Hypoxia-inducible factor (HIF)-1 alpha accumulation promotes hematopoietic stem cells' quiescence an...
The eleven-nineteen lysine-rich leukemia (ELL) gene undergoes translocation and fuses in-frame to th...
Oncogenesis is governed by genetic and epigenetic events that co-opt to malignant progression. The r...
ELL (eleven-nineteen lysine-rich leukemia protein) was first identified as a translocation partner o...
Background: U19/EAF2 is a potential tumor suppressor exhibiting frequent down-regulation and allelic...
Previous studies revealed that the potential tumor suppressor EAF2 binds to and stabilizes pVHL, sug...
Primary effusion lymphoma (PEL) is an aggressive B-cell lymphoma with poor prognosis caused by Kapos...
Matching oxygen consumption and supply represents a fundamental challenge to multicellular organisms...
AbstractChronic lymphocytic leukemia (CLL), the most common adult leukemia in the Western world, is ...
Overcoming resistance to chemotherapy is the main therapeutic challenge in the treatment of acute ly...
The mechanisms by which AML1/ETO (A/E) fusion protein induces leukemogenesis in acute myeloid leukem...
The objective of this study was to determine the effect of hypoxic conditions on the expression of H...
The mechanisms by which AML1/ETO (A/E) fusion protein induces leukemogenesis in acute myeloid leukem...
Rampant activity of the hypoxia-inducible factor (HIF)-1 in cancer is frequently associated with the...
Upon exposing mammalian tissues to hypoxia, expression of a number of physiologically important gene...
Hypoxia-inducible factor (HIF)-1 alpha accumulation promotes hematopoietic stem cells' quiescence an...
The eleven-nineteen lysine-rich leukemia (ELL) gene undergoes translocation and fuses in-frame to th...
Oncogenesis is governed by genetic and epigenetic events that co-opt to malignant progression. The r...